CDTX
Cidara Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CDTX fundamentals
Cidara Therapeutics (CDTX) released its earnings on Nov 6, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -3.1 (YoY -26.53%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-3.1
-26.53%
Report date
Nov 6, 2025
CDTX Earnings Call Summary for Q3,2025
- Phase III Trial Acceleration: CD388 Phase III ANCHOR trial initiated six months early, with 6,000 participants (50% enrolled) across 150 sites.
- FDA Recognition: Breakthrough Therapy Designation and Fast Track Status enhance regulatory engagement.
- BARDA Funding: $339M to support U.S. manufacturing and expanded clinical development, including pandemic preparedness studies.
- Market Potential: Addressable population expanded to >100M in the U.S., with 76.1% efficacy demonstrated in Phase IIb.
- Manufacturing Readiness: Initial 5M doses/year production capacity with WuXi, U.S. scale-up via BARDA, and global partners for long-term supply.
- Pandemic Preparedness: Preclinical data shows efficacy against H5N1 and neuraminidase-resistant strains, positioning for government stockpiling discussions.
EPS
Revenue
Revenue & Expenses
Key Indicators
Cidara Therapeutics (CDTX) key financial stats and ratios, covering profitability, financial health, and leverage.
Cidara Therapeutics (CDTX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Cidara Therapeutics (CDTX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cidara Therapeutics (CDTX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Cidara Therapeutics (CDTX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Cidara Therapeutics (CDTX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Cidara Therapeutics's latest dividend and current dividend yield?Did Cidara Therapeutics beat or miss consensus estimates last quarter?What does Cidara Therapeutics do and what are its main business segments?What were the key takeaways from Cidara Therapeutics’s earnings call?What guidance did Cidara Therapeutics's management provide for the next earnings period?What were the key takeaways from Cidara Therapeutics's earnings call?What is the revenue and EPS growth rate for Cidara Therapeutics year over year?What is the market's earnings forecast for Cidara Therapeutics next quarter?
